Kronos Bio, Inc. (KRON)

Kronos Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-112.67	-133.2	-151.08	-88.44	-16.12
Depreciation & Amortization	4.92	4.46	4.08	4.87	0.61
Share-Based Compensation	24.98	31.15	26.21	3.75	0.11
Other Operating Activities	4.19	6.67	2.86	41.91	0.32
Operating Cash Flow	-78.58	-90.93	-117.92	-37.91	-15.08
Capital Expenditures	-0.68	-0.58	-4.26	-9.57	-2.95
Change in Investments	67.05	-31.65	67.98	-150.67	-64.63
Investing Cash Flow	66.37	-32.22	63.72	-160.24	-67.58
Share Issuance / Repurchase	0.57	0.85	4.47	264.37	0.12
Debt Issued / Paid	0	0	-0.01	151.24	-0.03
Other Financing Activities	-	-	-	-	104.92
Financing Cash Flow	0.57	0.85	4.46	415.61	105.01
Net Cash Flow	-11.65	-122.3	-49.74	217.47	22.34
Free Cash Flow	-79.26	-91.5	-122.18	-47.48	-18.03
Free Cash Flow Margin	-1260.51%	-	-	-	-
Free Cash Flow Per Share	-1.37	-1.63	-2.23	-2.92	-3.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).